Lexaria Bioscience Corp. (LEXX)
3.90
-0.15
(-3.70%)
USD |
NASDAQ |
Sep 11, 12:05
Lexaria Bioscience Gross Profit (TTM) : 0.095M for May 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.095M |
| February 28, 2026 | 0.2804M |
| November 30, 2025 | 0.4432M |
| August 31, 2025 | 0.6154M |
| May 31, 2025 | 0.5304M |
| February 28, 2025 | 0.4408M |
| November 30, 2024 | 0.4136M |
| August 31, 2024 | 0.3724M |
| May 31, 2024 | 0.3447M |
| February 29, 2024 | 0.2682M |
| November 30, 2023 | 0.1862M |
| May 31, 2023 | 0.1137M |
| February 28, 2023 | 0.1232M |
| November 30, 2022 | 0.1211M |
| August 31, 2022 | 0.0467M |
| May 31, 2022 | -0.0048M |
| February 28, 2022 | 0.0619M |
| November 30, 2021 | 0.2051M |
| August 31, 2021 | 0.4357M |
| May 31, 2021 | 0.4416M |
| February 28, 2021 | 0.3134M |
| November 30, 2020 | 0.1311M |
| August 31, 2020 | -0.0972M |
| May 31, 2020 | -0.0849M |
| February 29, 2020 | -0.0388M |
| Date | Value |
|---|---|
| November 30, 2019 | 0.0127M |
| August 31, 2019 | 0.0561M |
| May 31, 2019 | 0.1477M |
| February 28, 2019 | 0.2509M |
| November 30, 2018 | 0.4061M |
| August 31, 2018 | 0.4058M |
| May 31, 2018 | 0.3207M |
| February 28, 2018 | 0.203M |
| November 30, 2017 | 0.0426M |
| August 31, 2017 | 0.0324M |
| May 31, 2017 | 0.0307M |
| February 28, 2017 | 0.0075M |
| November 30, 2016 | 0.006M |
| August 31, 2016 | -0.0055M |
| May 31, 2016 | -0.0247M |
| February 29, 2016 | -0.0237M |
| November 30, 2015 | -0.0188M |
| August 31, 2015 | -0.0152M |
| May 31, 2015 | 0.0521M |
| February 28, 2015 | 0.1121M |
| November 30, 2014 | 0.1447M |
| July 31, 2014 | 0.1542M |
| April 30, 2014 | 0.1766M |
| January 31, 2014 | 0.2073M |
| October 31, 2013 | 0.3023M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Target Group, Inc. (Canada) | 0.4683M |
| InMed Pharmaceuticals, Inc. | -0.1222M |
| NervGen Pharma Corp. | -0.0404M |
| Milestone Pharmaceuticals, Inc. | 2.125M |
| Clearmind Medicine, Inc. | -0.0526M |